Suppr超能文献

发作性睡病-猝倒症与精神病:一项病例研究。

Narcolepsy-cataplexy and psychosis: a case study.

作者信息

Canellas-Dols F, Delgado C, Arango-Lopez C, Peraita-Adrados R

机构信息

Hospital Universitario Son Espases, Palma de Mallorca, Espana.

CIBERSAM, Madrid, Espana.

出版信息

Rev Neurol. 2017 Jul 16;65(2):70-74.

Abstract

AIMS

To report a challenging patient a girl who developed narcolepsyy with cataplexy (NT1) and a psychosis during adolescence. To discuss diagnostic and therapeutic challenges of the comorbid cases.

CASE REPORT

A 14-year-old girl was referred to Sleep and Epilepsy Unit for excessive daytime sleepiness, impaired nocturnal sleep, binge eating and weight gain, over the last year. After being diagnosed with a NT1 the patient was treated with modafinil and sodium oxybate. She was hospitalized for psychotic symptoms after starting NT1 treatment. Withdrawal of the narcolepsy treatment and initiation of haloperidol 1 mg/day (the only antipsychotic treatment she could tolerate) improved the delusions, hallucinations and dysphoria but worsened the narcolepsy symptoms. Polysomnography showed fragmented nocturnal sleep and five sleep REM onset periods in MSLT. Positive HLA-QB1*06:02 and undetectable level of hypocretine in the cerebrospinal fluid were found. MRI and CT-scan were normal. Diagnostic Interview for Genetic Studies Adapted for Narcolepsy (DIGSAN) questionnaire confirmed that patient presented a dual diagnostic NT1 and psychotic symptoms. The last sleep follow-up while on psychopharmacological treatment, showed an increased sleep efficiency index. She currently has severe somnolence, obesity, and partial cataplectic attacks along with normal mood, academic failure and social isolation.

CONCLUSION

The coexistence of narcolepsy with psychoses is a rare clinical entity, more frequent in adolescents than in adults. The comorbidity of the two illnesses worsens clinical and therapeutic prognosis and also suggests interesting pathophysiological hypotheses.

摘要

目的

报告一名具有挑战性的患者,一名在青春期出现发作性睡病伴猝倒(NT1)和精神病的女孩。讨论合并病例的诊断和治疗挑战。

病例报告

一名14岁女孩因过去一年出现白天过度嗜睡、夜间睡眠障碍、暴饮暴食和体重增加,被转诊至睡眠与癫痫科。在被诊断为NT1后,患者接受了莫达非尼和羟丁酸钠治疗。开始NT1治疗后,她因精神病症状住院。停用发作性睡病治疗并开始使用1毫克/天的氟哌啶醇(她唯一能耐受的抗精神病药物治疗)改善了妄想、幻觉和烦躁不安,但加重了发作性睡病症状。多导睡眠图显示夜间睡眠碎片化,多次睡眠潜伏期试验中有5个睡眠快速眼动期开始。发现脑脊液中HLA-QB1*06:02呈阳性且下丘脑分泌素水平检测不到。磁共振成像和计算机断层扫描均正常。适用于发作性睡病的基因研究诊断访谈(DIGSAN)问卷证实患者呈现NT1和精神病症状的双重诊断。在接受精神药物治疗期间的最后一次睡眠随访显示睡眠效率指数有所提高。她目前有严重嗜睡、肥胖和部分猝倒发作,同时情绪正常、学业失败和社交孤立。

结论

发作性睡病与精神病并存是一种罕见的临床情况,在青少年中比在成年人中更常见。两种疾病的合并会恶化临床和治疗预后,也提出了有趣的病理生理假设。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验